Clinical Trial Update: Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial update for TRIMELVax in patients with stage IIIC/IV melanoma, conducted by the University of Chile. The current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• TRIMELVax

Snippet

Sponsor: University of Chile | Conditions: Melanoma Stage IIIc, Melanoma Stage IV | Phase 1 | Status: UNKNOWN